Bank of New York Mellon Corp Has $157.51 Million Stock Holdings in Waters Corporation $WAT

Bank of New York Mellon Corp grew its stake in shares of Waters Corporation (NYSE:WAT) by 63.6% during the 1st quarter, Holdings Channel reports. The firm owned 528,908 shares of the medical instruments supplier’s stock after buying an additional 205,678 shares during the period. Bank of New York Mellon Corp’s holdings in Waters were worth $157,509,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Anchor Investment Management LLC bought a new position in shares of Waters in the 1st quarter valued at about $27,000. Zions Bancorporation National Association UT grew its holdings in Waters by 121.2% during the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 40 shares during the period. Louisbourg Investments Inc. bought a new position in Waters during the first quarter worth about $30,000. Riverview Trust Co acquired a new position in Waters during the first quarter worth approximately $30,000. Finally, First United Bank & Trust acquired a new position in Waters during the first quarter worth approximately $31,000. Institutional investors own 94.01% of the company’s stock.

Waters Price Performance

WAT stock opened at $368.82 on Monday. The company has a quick ratio of 1.13, a current ratio of 1.79 and a debt-to-equity ratio of 0.32. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15. The firm has a market cap of $36.21 billion, a P/E ratio of 46.86, a P/E/G ratio of 2.23 and a beta of 1.20. The company’s 50-day moving average price is $362.09 and its two-hundred day moving average price is $346.27.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, beating the consensus estimate of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.20 billion. During the same period in the previous year, the business earned $2.25 earnings per share. The company’s revenue was up 91.4% on a year-over-year basis. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, analysts anticipate that Waters Corporation will post 14.51 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently weighed in on WAT. The Goldman Sachs Group increased their price target on Waters from $380.00 to $425.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. HSBC lifted their price objective on shares of Waters from $415.00 to $435.00 and gave the stock a “buy” rating in a research report on Wednesday, June 3rd. Bank of America increased their price objective on shares of Waters from $370.00 to $400.00 and gave the company a “neutral” rating in a research report on Tuesday, June 2nd. Piper Sandler began coverage on shares of Waters in a research note on Thursday, June 11th. They set a “neutral” rating and a $400.00 target price for the company. Finally, Robert W. Baird set a $387.00 target price on shares of Waters in a report on Wednesday, May 6th. Three analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, Waters has a consensus rating of “Moderate Buy” and an average price target of $401.60.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.